RIAs. Samples were rehydrated in phosphate-buffered saline (pH 1.6) containing 0.1% gelatin, 0.1% bovine serum albumin, 0.1% Triton X-100, and 0.01% merthiolate. Antisera were used at final dilutions of 1:100,000 for Dyn A, 1:120,000 for Dyn A-(1-8) and Dyn B, 1:60,000 for a-neoendorphin, 1:10,000 for /3-neo-endorphin, 1:100,000 for [Leu]Enk, and 1:75,000 for [Met]Enk-Arg-Gly-Leu, which resulted in 30-45% uncompeted binding of the trace. The RIA for Dyn A, Dyn A-(1-8), Dyn B, a-neo-endorphin, and ,l3neo-endorphin was used as described (12-16). A doubleantibody RIA for [Leu]Enk and [Met]Enk-Arg-Gly-Leu was performed as described here. Each sample was incubated in a 500-,ul volume that contained 300 ,ul of sample in assay buffer and 100 ,ul of 125I-labeled opioid peptide (about 6000 cpm). Normal rabbit serum (NRS) was also added to the first antibody solution to give a total rabbit serum concentration of 1%; 100 ,ul of this solution was added to all except "nonspecific binding" tubes, which received 100 ,ul of 1% NRS in assay buffer. Reagents were mixed and the tubes were incubated for 16-24 hr. One hundred microliters of goat anti-rabbit gamma globulin diluted with assay buffer to a concentration sufficient for maximal precipitation was added to all tubes. The reagents were mixed and the tubes were incubated for 16-24 hr. After incubation with the second antibody, all tubes were centrifuged for 20 min at 2000 x g at 40C. The supernatant was aspirated and pellets were assayed for radioactivity (-counter 
[Met]enkephalin ([Met]Enk) and single copies of [Leu] Enk, [Met] Enk-Arg6-Gly7-Leu8 ([Met] Enk-Arg-Gly-Leu), and [Met]Enk-Arg6-Phe7, which are contained within larger peptide sequences such as BAM 22P and peptides I, F, E, and B (1, 4, 5) . It is clear that the enkephalin-and dynorphin-containing neuronal systems in brain are anatomically distinct from each other and from the ,B-endorphin-containing neuronal systems (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . However, because of the existence of overlapping enkephalin and dynorphin/neo-endorphin circuits in the hypothalamus, hippocampus, and presumably other brain regions, the relationship between these two neuronal systems needs further clarification. In the present study, prodynorphin and proenkephalin-derived peptides were measured, by specific RIAs, in selected areas of the rat brain. These two polypeptide families are differentially distributed throughout the brain.
[Leu]Enk probably derives from proenkephalin in some brain areas and from prodynorphin in others, or from both precursors.
MATERIALS AND METHODS
Preparation of Extracts for RIAs. Rats (Sprague-Dawley, male, 220-250 g) were killed by decapitation (between 08:00 and 10:00 hr). The brains were quickly removed and frozen on dry ice. Brain regions were removed by the micropunch technique, from 300-,um thick frozen coronal sections cut in a cryostat at -10°C (21) . Tissue samples were placed in Eppendorf tubes containing 200 M1 of 0.1 M HC1 and transferred to a boiling water bath for 10 min. Samples were chilled in ice and then homogenized by sonication, and 20-,u aliquots of the homogenates were removed for protein determination (22) . The extracts were centrifuged at 2000 x g for 10 min at 4°C. The supernatants were transferred to 12 x 75 mm polypropylene or polystyrene tubes (the latter for RIAs of
[Leu]Enk and [Met]Enk-Arg-Gly-Leu) and evaporated to dryness in a vacuum centrifuge.
RIAs. Samples were rehydrated in phosphate-buffered saline (pH 1.6) containing 0.1% gelatin, 0.1% bovine serum albumin, 0.1% Triton X-100, and 0.01% merthiolate. Antisera were used at final dilutions of 1:100,000 for Dyn A, 1:120,000 for Dyn A-(1-8) and Dyn B, 1:60,000 for a-neoendorphin, 1:10,000 for /3-neo-endorphin, 1 [Leu]Enk, a-neo-endorphin, or f3-neo-endorphin. The crossreactivity of Dyn A-(1-9) is only 1%. It does not crossreact with [Met] Enk-Arg-Gly-Leu. The crossreactivity of f3-neoendorphin with a-neo-endorphin and a-neo-endorphin with f3neo-endorphin is <1%. The neo-endorphin antisera (25) (1984) in Fig. LA, which figure is about 1.2) . Variations in the steady-state concentrations of these two peptides could result from differences in their rate of release, generation, or intracellular breakdown (2) . It is possible that peptides residing in the game granule might be secreted selectively and that the intracellular breakdown of various enkephalins may pro- 
